HK1156690A1 - Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack - Google Patents

Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack

Info

Publication number
HK1156690A1
HK1156690A1 HK11110809.7A HK11110809A HK1156690A1 HK 1156690 A1 HK1156690 A1 HK 1156690A1 HK 11110809 A HK11110809 A HK 11110809A HK 1156690 A1 HK1156690 A1 HK 1156690A1
Authority
HK
Hong Kong
Prior art keywords
procalcitonin
guidance
diagnosis
patients
bacterial infections
Prior art date
Application number
HK11110809.7A
Other languages
English (en)
Chinese (zh)
Inventor
Andreas Bergmann
Oliver Hartmann
Frauke Hein
Beat Muller
Original Assignee
有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41362428&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1156690(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 有限公司 filed Critical 有限公司
Publication of HK1156690A1 publication Critical patent/HK1156690A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/585—Calcitonins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK11110809.7A 2009-10-13 2011-10-12 Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack HK1156690A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09012947 2009-10-13

Publications (1)

Publication Number Publication Date
HK1156690A1 true HK1156690A1 (en) 2012-06-15

Family

ID=41362428

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11110809.7A HK1156690A1 (en) 2009-10-13 2011-10-12 Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack

Country Status (6)

Country Link
US (1) US8383332B2 (xx)
EP (1) EP2320237B1 (xx)
JP (2) JP5722587B2 (xx)
CN (1) CN102081101B (xx)
ES (1) ES2601104T3 (xx)
HK (1) HK1156690A1 (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101790687A (zh) * 2007-08-03 2010-07-28 B.R.A.H.M.S有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用
EP2320237B1 (en) 2009-10-13 2016-08-03 B.R.A.H.M.S GmbH Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
ITRM20100121A1 (it) * 2010-03-18 2011-09-19 Univ Pisa Marcatori molecolari per infezioni delle vie urinarie.
CN102305858B (zh) * 2011-07-26 2013-08-21 深圳市国赛生物技术有限公司 一种检测降钙素原的试剂盒
JP6661607B2 (ja) 2014-08-14 2020-03-11 メメド ダイアグノスティクス リミテッド 多様体および超平面を用いる生物学的データのコンピュータ分析
CA2992343A1 (en) * 2015-07-13 2017-01-19 University Of Geneva Biomarker panels for brain injury complications
CA3015046A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
AU2017246588A1 (en) * 2016-04-08 2018-09-27 Centre National De La Recherche Scientifique - Cnrs - Methods and kits for diagnosing postoperative pulmonary infections in patients who underwent surgery
CN107490683A (zh) * 2016-06-09 2017-12-19 常州博闻迪医药科技有限公司 一种唾液降钙素原胶体金检测方法
CN107490679A (zh) * 2016-06-09 2017-12-19 常州博闻迪医药科技有限公司 一种唾液降钙素原酶联免疫检测方法
WO2018011796A1 (en) * 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Early diagnosis of infections
WO2018114044A1 (en) * 2016-12-22 2018-06-28 University Of Geneva Biomarker panels for brain injury complications
EP3438668A1 (en) 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections
JP7346389B2 (ja) 2017-09-13 2023-09-19 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 異常な血小板レベルのマーカーとしてのプロアドレノメジュリン
EP3502706A1 (en) * 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
WO2019122088A1 (en) 2017-12-20 2019-06-27 B.R.A.H.M.S Gmbh Antibiotic therapy guidance based on procalcitonin in patients with comorbidities
US20210109118A1 (en) * 2017-12-20 2021-04-15 B.R.A.H.M.S Gmbh Antibiotic therapy guidance based on pro-adm
BR112022008068A2 (pt) 2019-10-28 2022-07-12 Hoffmann La Roche Métodos para auxiliar na avaliação de risco de um paciente com suspeita de sepse e método implementado por computador para a avaliação de um paciente com suspeita de sepse
KR102362951B1 (ko) * 2020-08-13 2022-02-14 연세대학교 원주산학협력단 프로칼시토닌 대 ｃ­반응성 단백질의 비율을 이용한 허혈성 뇌졸중의 단기 사망률 예측 방법
EP4330688A2 (en) 2021-04-30 2024-03-06 Roche Diagnostics GmbH Pct marker panels for early detection of sepsis
JP2024515086A (ja) 2021-04-30 2024-04-04 エフ． ホフマン－ラ ロシュ アーゲー 敗血症の早期検出のためのｇｄｆ１５マーカーパネル
WO2022229440A2 (en) 2021-04-30 2022-11-03 F. Hoffmann-La Roche Ag Sflt1 marker panels for early detection of sepsis
JP2024516679A (ja) 2021-04-30 2024-04-16 エフ． ホフマン－ラ ロシュ アーゲー 敗血症の早期検出用のｉｇｆｂｐ７マーカーパネル

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3147470A1 (de) 1981-12-01 1983-07-14 Bizerba-Werke Wilhelm Kraut GmbH & Co KG, 7460 Balingen Kraftmessvorrichtung
DE19600875C1 (de) * 1996-01-12 1997-06-26 Brahms Diagnostica Gmbh Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse
US5993811A (en) * 1997-02-03 1999-11-30 Biology Associates, Llc Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
DE112004001863T5 (de) * 2003-10-03 2006-09-07 Scantibodies Laboratory, Inc., Santee Verfahren und Verwendung von Bindungskomponenten zur Verbesserung der Testspezifität
CN101029897A (zh) * 2007-02-09 2007-09-05 深圳市新产业生物医学工程有限公司 一种降钙素原测试试剂盒及其测试方法
DE102007009751A1 (de) * 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
EP2167965B1 (de) * 2007-06-22 2013-04-10 B.R.A.H.M.S GmbH Verfahren zur detektion von analyten
CN101790687A (zh) 2007-08-03 2010-07-28 B.R.A.H.M.S有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用
EP2101178A1 (en) * 2008-03-12 2009-09-16 BRAHMS Aktiengesellschaft Use of Procalcitonin (PCT) in prognosis following acute coronary syndromes
EP2020603A1 (en) * 2007-08-03 2009-02-04 BRAHMS Aktiengesellschaft Method for risk stratification in stable coronary artery disease
GB0722729D0 (en) * 2007-11-20 2007-12-27 Bristol Myers Squibb Co Diagnostic markers of wound infection
EP2320237B1 (en) 2009-10-13 2016-08-03 B.R.A.H.M.S GmbH Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack

Also Published As

Publication number Publication date
EP2320237B1 (en) 2016-08-03
EP2320237A1 (en) 2011-05-11
JP2011085586A (ja) 2011-04-28
US20110086831A1 (en) 2011-04-14
JP5722587B2 (ja) 2015-05-20
ES2601104T3 (es) 2017-02-14
JP2015057611A (ja) 2015-03-26
CN102081101A (zh) 2011-06-01
CN102081101B (zh) 2014-08-20
US8383332B2 (en) 2013-02-26

Similar Documents

Publication Publication Date Title
HK1156690A1 (en) Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
HK1179695A1 (zh) 降鈣素原用於在具有非特異性不適的患者中診斷細菌感染和指導抗生素治療
EP2408753A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF MICROBIAL STOMACH DARM INFECTIONS IN MAMMALS
BR112013011693A2 (pt) derivados de ácido hidroxâmico e seu uso no tratamento de infecções por bactérias
PL2996700T3 (pl) Kompozycja zawierająca bakterie kwasu mlekowego do stosowania w zapobieganiu i/lub leczeniu zakażeń i/lub stanów zapalnych dróg moczowych i/lub pęcherza moczowego
IL213070A0 (en) Methods for the treatment of infections and tumors
EP2456891A4 (en) DIAGNOSIS, DETECTION, QUANTIFICATION UNIVERSAL MICROBIENS, AND TARGETED THERAPY ON A SAMPLE
ZA201005798B (en) Treatment of microbial infections
EP2490530A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP2335072A4 (en) METHOD AND DEVICE FOR COMBINED DETECTION OF VIRAL AND BACTERIAL INFECTIONS
BRPI0924902A2 (pt) Linhagens de bactérias com alta atividade anti-inflamatória
PL2249824T3 (pl) Laktylany w zapobieganiu i leczeniu infekcji wywoływanych bakteriami gram-dodatnimi u zwierząt
PT2142186E (pt) Utilização de oligómeros de ácido láctico no tratamento de infeções ginecológicas
IL226289A0 (en) Derivatives of one–@–benzothiazin–@@@–h4–yl–1–piperazin–2 and their use in the treatment of mammalian infections
PT2575971E (pt) Extratos combinados de plantas para utilização no tratamento de infeções microbianas
BR112012025640A2 (pt) uso de streptococcus salivarius no tratamento de infecções crônicas do trato respiratório
CL2012003168A1 (es) Composicion farmaceutica que comprende una solucion acuosa de minociclina y un cation divalente o trivalente en una proporcion mayor de 2:1 con respecto a la minociclina; metodo de preparacion; kit y uso en el tratamiento de infecciones bacterianas.
EP2275154A4 (en) ANTIBACTERIAL COMPOSITION FOR MEDICAL USE AND MEDICAL DEVICE
GB201108964D0 (en) Medicament and method of diagnosis
AP3149A (en) Diagnostic test panel for the diagnostic of malaria and severe bacterial infections
FI20115377A0 (fi) Lääketieteelliset tuotteet käytettäviksi ylemmän hengitys- ja ruoansulatuskanavan mikrobi-infektioihin liittyvissä tiloissa
PL2895180T3 (pl) Kompozycja do zapobiegania i leczenia ostrych i nawracających zakażeń dróg moczowych
ZA201204249B (en) Treatment of microbial infections
CL2013003268A1 (es) Uso de una composición que comprende secnidazol y un antibiótico macrólido para preparar un medicamento útil en el tratamiento de infecciones dentales.
ZA201303631B (en) Detection and/or diagnosis of mite infections in sheep